AI assistant
Sending…
Teva Pharmaceutical Industries Ltd. — Call Transcript 2008
Jul 23, 2008
7082_rns_2008-07-23_8d4d9ccb-6d9c-4ae4-8ea4-1f14344c6cb6.htm
Call Transcript
Open in viewerOpens in your device viewer
_________ false
C003��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD.7217Corporation no: 520013954Stock Exchange/Market: ���310381P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267554 , 03-9267652 Fax: 03-9267519E.mail address: [email protected] of transmission: 23/07/2008 Time of broadcast: 11:35 11:31:13
Reference: 2008-02-213348
| Israel Securities Authority | Tel Aviv Stock Exchange | |||||
| www.isa.gov.il | www.tase.co.il |
Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000 The corporation is a foreign private issuer as defined by U.S. Securities Laws.
| Attached hereto is a report on | Transcript of teleconference held July 18, 2008, hosted by Teva Pharmaceutical Industries Limited and Barr Pharmaceuticals, Inc. |
teleconferencetranscript180708_isa.pdf
| Attached please find a report as filed with the U.S. authorities |
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): |
| Previous names of reporting entity: |
| Date of revision of form structure: 21/07/2008 |
| - - - |
| Name of the Signatory: : Desheh Eyal , Position of Signatory in the reporting corporation: Chief Financial Officer , Name of Employer Company: . |
| Basel Telephone: 02-9411717 , Facsimile: 02-9411718 , E-mail: [email protected] 2 |
More from Teva Pharmaceutical Industries Ltd.
Director's Dealing
2026
May 18
Regulatory Filings
2026
May 18
Director's Dealing
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 4